Blood test may predict kidney danger in muscle injury patients

NCT ID NCT01544231

Completed Diagnosis Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 197 emergency room patients with rhabdomyolysis (severe muscle breakdown) to see if a blood test for a protein called NGAL could predict who would develop acute kidney failure within 48 hours. The goal is to help doctors identify high-risk patients earlier and start treatment faster.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury Emergencies Rhabdomyolysis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY FAILURE RHABDOMYOLYSIS

Contacts and locations

Locations

APHP - Groupe Hospitalier Pitié-Salpetrière

Paris, 75651, France
CHU de Montpellier - Hôpital Lapeyronie

Montpellier, 34295, France
CHU de Nice - Hôpital St-Roch

Nice, 06006, France
CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, Gard, 30029, France
Hôpital Interarmées Sainte Anne

Toulon, 83800, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.